Furthermore, by knocking down β-galactoside α2-6-sialyltransferase ST6Gal-1, which catalyzes the addition of sialic acid to galactose, ovarian tumor cells gained cisplatin resistance [30]. Here, ST6GAL1 is linked to ovarian neoplasm.